Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 2010

View Archived Issues

Memory Pharmaceuticals claims novel 5-HT6 receptor ligands

Triad Multitech claims new nitrogen- and sulfur-containing agents

TransTech Pharma patents novel modulators of the AgRP-MC4 receptor interaction

New butyrylcholinesterase ligands claimed by Treventis as diagnostic agents

Galderma discovers novel LXRbeta ligands

Merck and Ligand identify new beta-secretase 1 inhibitors with potential in Alzheimer's disease

ASPIRE study finds no benefit of add-on aliskiren on end systolic volume after myocardial infarction

PERSEUS data support efficacy of Taxus Element paclitaxel-eluting stent

Preclinical data disclosed on S1P1 receptor agonist PF-991 for treatment of autoimmune disorders

European Commission approves DuoPlavin/DuoCover dual antiplatelet combination tablet

Merck Serono temporarily suspends worldwide clinical development program of Stimuvax

Santarus completes enrollment in second U.S. phase III trial of budesonide in ulcerative colitis

Penn Medicine and AstraZeneca collaborate to discover new Alzheimer's disease therapeutics

Tysabri enters head-to-head phase III trial for multiple sclerosis

Preclinical data on novel orally active FXa inhibitor TAK-442 presented at ACS Meeting

Shire presents data from patients with Gaucher's disease who switched to VPRIV

Dara BioSciences begins phase I trial of DB-959 in type 2 diabetes

Takeda submits application in Japan for additional indications for alogliptin

EyeGate Pharma completes phase II EGP-437 study in uveitis

Health Canada approves Avastin for glioblastoma multiforme

CryoLife withdraws proposal to acquire Medafor

Transcept updates plan for Intermezzo NDA resubmission

Portola begins phase I trial of oral SYK inhibitor PRT-062607 for inflammatory disease and cancer

Bionomics to initiate second phase II trial of BNC-105 for advanced mesothelioma

DMC recommends continued enrollment in eritoran phase III trial for severe sepsis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...